Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story
Gout is associated with a high risk of cardiovascular diseases and associated mortality. Possible causes of the disease include persistent uncontrolled hyperuricemia, a chronic microcrystalline inflammation that develops in the vascular wall and even in atherosclerotic plaques. These processes, whic...
Saved in:
| Main Authors: | M. S. Eliseev, O. V. Zhelyabina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2023-08-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01) -
Xanthine oxidase inhibitors in asymptomatic hyperuricemia
by: O. V. Zhelyabina, et al.
Published: (2019-10-01) -
Proteoglycan 4 (Lubricin) and regulation of xanthine oxidase in synovial macrophage as a mechanism of controlling synovitis
by: Khaled A. Elsaid, et al.
Published: (2024-12-01) -
Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01) -
A Review on Xanthine Oxidase-Based Electrochemical Biosensors: Food Safety and Quality Control Applications
by: Totka Dodevska
Published: (2025-05-01)